Medical ProductsCompany
Mahana Therapeutics - IBS Assets Ownership
Who owns Mahana Therapeutics - IBS Assets?
Mahana Therapeutics - IBS Assets is owned by Nerva. It was acquired on May 6, 2025.
Mahana Therapeutics - IBS Assets Business Overview
Where is Mahana Therapeutics - IBS Assets headquartered?
Mahana Therapeutics - IBS Assets is headquartered in San Francisco, California.
What sector is Mahana Therapeutics - IBS Assets in?
Mahana Therapeutics - IBS Assets is a medical products company.
Medical Products M&A Summary in 2025
Out of 60 sectors in the Mergr database, medical products ranked 18 in number of deals in 2025. The largest medical products acquisition in 2025 was Inari Medical - which was acquired by Stryker for $4.9B.
Join Mergr to view all 53 acquisitions of medical products companies in 2025, including 5 acquisitions by private equity firms, and 48 by strategics.